Abstract | AIMS AND METHODS: Acute myocardial infarction (AMI) is a common cardiovascular disease with high mortality. Astragaloside IV (AS-IV) was reported to have cardioprotective effect after AMI. We hypothesize that the cardioprotective role of AS-IV is exerted by enhancing angiogenesis via regulating PTEN/PI3K/Akt signaling pathway. To valid our hypothesis, AMI rats and human umbilical vein endothelial cells (HUVECs) were employed in our study. KEY FINDINGS:
After treatment, cardiac function, survival rate, infarct size, pathological changes and fibrosis, cell apoptosis, ultrastructural changes, angiogenesis and expression of PTEN/PI3K/Akt signaling pathway were evaluated, respectively. In vitro study we detected proliferation, tube formation and signaling pathway activation of HUVECs treated with AS-IV, lentivirus overexpressed PTEN was employed to elucidate the potential mechanism. The results indicated that AS-IV administration significantly improved cardiac function and survival rate, limited infarct size, ameliorated pathological changes and fibrosis deposition, inhibited apoptosis, relieved ultrastructure injury and enhanced angiogenesis, PTEN/PI3K/Akt signaling pathway was activated simultaneously compared to the model group. In vitro study suggested that AS-IV treatment promoted cell proliferation and tube formation, and induced PTEN/PI3K/Akt signaling pathway activation. Importantly, overexpression of PTEN by lentivirus abolished AS-IV-induced angiogenesis. SIGNIFICANCE: Our study indicated that AS-IV could promote angiogenesis and cardioprotection after myocardial infarction. The mechanisms involve activation of PTEN/PI3K/Akt signaling pathway.
|
Authors | Songyi Cheng, Xiaoxiao Zhang, Qian Feng, Jiandong Chen, Le Shen, Peng Yu, Li Yang, Daohai Chen, Haowen Zhang, Weixin Sun, Xiaohu Chen |
Journal | Life sciences
(Life Sci)
Vol. 227
Pg. 82-93
(Jun 15 2019)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 31004658
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 Elsevier Inc. All rights reserved. |
Chemical References |
- Angiogenesis Inducing Agents
- Cardiotonic Agents
- Saponins
- Triterpenes
- Vascular Endothelial Growth Factor A
- astragaloside A
- Phosphatidylinositol 3-Kinases
- Proto-Oncogene Proteins c-akt
- PTEN Phosphohydrolase
|
Topics |
- Angiogenesis Inducing Agents
- Animals
- Apoptosis
(drug effects)
- Cardiotonic Agents
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Human Umbilical Vein Endothelial Cells
- Humans
- Male
- Myocardial Infarction
(drug therapy, metabolism)
- Neovascularization, Pathologic
(metabolism)
- PTEN Phosphohydrolase
(drug effects, metabolism)
- Phosphatidylinositol 3-Kinases
(drug effects, metabolism)
- Proto-Oncogene Proteins c-akt
(drug effects, metabolism)
- Rats
- Rats, Sprague-Dawley
- Saponins
(metabolism, pharmacology)
- Signal Transduction
(drug effects)
- Triterpenes
(metabolism, pharmacology)
- Vascular Endothelial Growth Factor A
(metabolism)
|